07/28/2025
7:52 PM | Blueprint Medicines (Filer)
| Form 15-12G | |
07/24/2025
11:15 PM | Blueprint Medicines (Filer)
| Form EFFECT | |
07/21/2025
6:44 PM | Albers Jeffrey W. (Reporting)
Blueprint Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/21/2025
6:44 PM | Blueprint Medicines (Issuer)
Lee Philina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/21/2025
6:44 PM | Blueprint Medicines (Issuer)
Durso-Bumpus Debra (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/21/2025
6:45 PM | Blueprint Medicines (Issuer)
McCain Tracey L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/21/2025
6:45 PM | Beckman Daniella (Reporting)
Blueprint Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/21/2025
6:45 PM | Blueprint Medicines (Issuer)
Namouni Fouad (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/21/2025
6:46 PM | Blueprint Medicines (Issuer)
Goldberg Mark Alan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/21/2025
6:46 PM | Blueprint Medicines (Issuer)
Borisy Alexis (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/21/2025
6:47 PM | Blueprint Medicines (Issuer)
Haviland Kate (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for BPMC and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Blueprint Medicines and its competitors with MarketBeat's FREE daily newsletter. |
07/21/2025
6:47 PM | Blueprint Medicines (Issuer)
Rossi Christina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/21/2025
6:47 PM | Blueprint Medicines (Issuer)
Carter Percy H. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/21/2025
6:48 PM | Blueprint Medicines (Issuer)
Seely Lynn (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/21/2025
6:48 PM | Blueprint Medicines (Issuer)
Hewes L. Becker (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/21/2025
6:49 PM | Blueprint Medicines (Issuer)
COATS LONNEL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/21/2025
6:49 PM | Blueprint Medicines (Issuer)
Tsai John (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/21/2025
6:49 PM | Blueprint Medicines (Issuer)
Hurley Ariel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/21/2025
6:50 PM | Blueprint Medicines (Issuer)
Dable Habib J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/21/2025
6:50 PM | Blueprint Medicines (Issuer)
Landsittel Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/18/2025
3:14 PM | Blueprint Medicines (Filer)
| Form S-8 POS | |
07/18/2025
3:15 PM | Blueprint Medicines (Filer)
| Form S-8 POS | |
07/18/2025
3:17 PM | Blueprint Medicines (Filer)
| Form S-8 POS | |
07/18/2025
1:58 PM | Blueprint Medicines (Subject)
Nasdaq Stock Market LLC (Filed by)
| Form 25-NSE | |
07/18/2025
5:09 AM | Blueprint Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/17/2025
5:40 AM | Blueprint Medicines (Subject)
| Form SC 14D9/A | |
07/17/2025
5:04 AM | Blueprint Medicines (Subject)
Sanofi (Filed by)
Sanofi (Filed by)
| Form SC TO-T/A | |
07/10/2025
5:18 AM | Blueprint Medicines (Subject)
| Form SC 14D9/A | |
07/10/2025
5:04 AM | Blueprint Medicines (Subject)
Sanofi (Filed by)
Sanofi (Filed by)
| Form SC TO-T/A | |
07/08/2025
3:20 PM | Blueprint Medicines (Issuer)
Carter Percy H. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/08/2025
3:20 PM | Blueprint Medicines (Issuer)
Rossi Christina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2025
3:23 PM | Blueprint Medicines (Issuer)
Borisy Alexis (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2025
3:24 PM | Beckman Daniella (Reporting)
Blueprint Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2025
3:25 PM | Blueprint Medicines (Issuer)
Seely Lynn (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2025
3:26 PM | Blueprint Medicines (Issuer)
Goldberg Mark Alan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2025
3:28 PM | Albers Jeffrey W. (Reporting)
Blueprint Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2025
7:04 AM | Blueprint Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/17/2025
6:06 AM | Blueprint Medicines (Subject)
| Form SC 14D9 | |
06/17/2025
5:07 AM | Blueprint Medicines (Subject)
Sanofi (Filed by)
Sanofi (Filed by)
| Form SC TO-T | |
06/05/2025
3:22 PM | Blueprint Medicines (Issuer)
Carter Percy H. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2025
4:11 PM | Blueprint Medicines (Subject)
Sanofi (Filed by)
Sanofi (Filed by)
| Form SC TO-C | |
Trump set to Boost Social Security Checks by 400%? (Ad) If you're collecting or planning to collect social security...
You should see this presentation about President Trump's Executive Order #14196.
Legendary investor Louis Navellier believes it could soon not only save Social Security from collapse...
But BOOST benefits for millions of retirees by up to 400%.
No wonder the financial times called this new initiative... Click here to see the details because the stakes couldn't be any higher. |
06/02/2025
5:22 AM | Blueprint Medicines (Subject)
| Form SC14D9C | |
06/02/2025
5:09 AM | Blueprint Medicines (Subject)
Sanofi (Filed by)
Sanofi (Filed by)
| Form SC TO-C | |
06/02/2025
5:13 AM | Blueprint Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/27/2025
8:06 PM | Albers Jeffrey W. (Reporting)
Blueprint Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/21/2025
3:33 PM | Blueprint Medicines (Issuer)
Rossi Christina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2025
8:30 AM | Avoro Capital Advisors LLC (Filed by)
Blueprint Medicines (Subject)
| Form SCHEDULE 13G | |
05/12/2025
9:44 AM | Blueprint Medicines (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SCHEDULE 13G/A | |
05/05/2025
3:57 PM | Blueprint Medicines (Subject)
Hurley Ariel (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/01/2025
6:12 AM | Blueprint Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/24/2025
3:16 PM | Blueprint Medicines (Filer)
| Form DEF 14A | |
04/24/2025
3:20 PM | Blueprint Medicines (Filer)
| Form DEFA14A | |
04/23/2025
7:19 PM | BlackRock, Inc. (Filed by)
Blueprint Medicines (Subject)
| Form SCHEDULE 13G/A | |
04/03/2025
3:30 PM | Blueprint Medicines (Issuer)
Haviland Kate (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/26/2025
3:27 PM | Blueprint Medicines (Issuer)
Rossi Christina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/24/2025
4:04 PM | Blueprint Medicines (Subject)
Rossi Christina (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/17/2025
3:26 PM | Albers Jeffrey W. (Reporting)
Blueprint Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2025
3:36 PM | Albers Jeffrey W. (Reporting)
Blueprint Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
3:12 PM | Blueprint Medicines (Issuer)
McCain Tracey L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
3:13 PM | Blueprint Medicines (Issuer)
Namouni Fouad (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
3:14 PM | Blueprint Medicines (Issuer)
Rossi Christina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
3:15 PM | Blueprint Medicines (Issuer)
Hewes L. Becker (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
4:16 PM | Blueprint Medicines (Issuer)
Namouni Fouad (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
4:17 PM | Blueprint Medicines (Issuer)
Landsittel Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
4:18 PM | Blueprint Medicines (Issuer)
Carter Percy H. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
4:18 PM | Blueprint Medicines (Issuer)
Rossi Christina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
4:19 PM | Blueprint Medicines (Issuer)
Haviland Kate (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
4:20 PM | Blueprint Medicines (Issuer)
McCain Tracey L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
4:20 PM | Blueprint Medicines (Issuer)
Hurley Ariel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
4:21 PM | Blueprint Medicines (Issuer)
Lee Philina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2025
4:15 PM | Blueprint Medicines (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/13/2025
4:09 PM | Blueprint Medicines (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/13/2025
6:34 AM | Blueprint Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/23/2025
6:53 PM | Albers Jeffrey W. (Reporting)
Blueprint Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2025
6:54 PM | Blueprint Medicines (Issuer)
Rossi Christina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2025
6:56 PM | Blueprint Medicines (Issuer)
Haviland Kate (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2025
3:23 PM | Blueprint Medicines (Subject)
Murray Christopher K. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/21/2025
8:25 PM | Albers Jeffrey W. (Reporting)
Blueprint Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/17/2025
3:24 PM | Blueprint Medicines (Subject)
Murray Christopher K. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/15/2025
5:03 PM | Blueprint Medicines (Issuer)
Hurley Ariel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/15/2025
5:04 PM | Albers Jeffrey W. (Reporting)
Blueprint Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/14/2025
3:50 PM | Albers Jeffrey W. (Reporting)
Blueprint Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/13/2025
10:55 AM | Blueprint Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/20/2024
3:15 PM | Blueprint Medicines (Issuer)
Rossi Christina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2024
3:15 PM | Albers Jeffrey W. (Reporting)
Blueprint Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2024
4:17 PM | Albers Jeffrey W. (Reporting)
Blueprint Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/18/2024
3:31 PM | Blueprint Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/16/2024
6:51 PM | Blueprint Medicines (Issuer)
Hurley Ariel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2024
3:52 PM | Blueprint Medicines (Subject)
Hurley Ariel (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/03/2024
4:33 PM | Blueprint Medicines (Issuer)
Haviland Kate (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/02/2024
5:52 PM | Blueprint Medicines (Issuer)
Rossi Christina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Altucher: Trump’s Great Gain is starting (Ad) New Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Trump’s Great Gain” has officially begun.
Altucher believes select cryptos could turn $900 into $108,000 over the next 12 months — and he’s laying out the full gameplan in a new presentation. See Altucher’s Trump crypto prediction here |
11/29/2024
12:40 PM | Blueprint Medicines (Subject)
Haviland Kate (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/27/2024
5:51 PM | Blueprint Medicines (Subject)
Rossi Christina (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/22/2024
3:47 PM | Blueprint Medicines (Issuer)
COATS LONNEL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2024
3:23 PM | Blueprint Medicines (Subject)
COATS LONNEL (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/12/2024
12:44 PM | Albers Jeffrey W. (Reporting)
Blueprint Medicines (Subject)
| Form 144/A | |
11/07/2024
4:24 PM | Albers Jeffrey W. (Reporting)
Blueprint Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/30/2024
3:27 PM | Blueprint Medicines (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/30/2024
6:07 AM | Blueprint Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/04/2024
4:09 PM | Blueprint Medicines (Issuer)
Namouni Fouad (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Free BPMC Stock Alerts